Physician

Amanda Murphy White, MD

According to 2025 Medicare claims, Amanda White, MD (NPI: 1730404997) practices pulmonary disease in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Cabarrus, NC. This provider's primary affiliated billing organization is THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (NPI: 1144657636; TIN: 560529945) and primary practice location at 28025-2927. White is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

White's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 250 traditional Medicare patients, billed 715 HCPCS/CPT codes, and received $44,871 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,809 prescription claims across 284 beneficiaries totaling $827,498 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 533 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $10,994 to $827,498. For DME billing, reported payments moved sharply higher in recent years, from $332 to $38,258.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	168	348	$27,924
2017	410	1,152	$86,290
2018	378	1,013	$74,409
2019	398	1,135	$83,702
2020	305	762	$62,247
2021	291	755	$73,362
2022	253	729	$62,032
2023	244	727	$49,832
2024	250	715	$44,871

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	24	$10,994
2016	54	107	$19,960
2017	145	582	$112,500
2018	150	709	$202,755
2019	171	795	$266,464
2020	183	947	$397,944
2021	176	939	$568,813
2022	191	1,000	$478,388
2023	266	1,456	$622,119
2024	284	1,809	$827,498

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$85
2017	61	495	$29,540
2018	75	616	$51,273
2019	79	773	$61,085
2020	71	859	$82,992
2021	46	542	$34,409
2022	17	357	$45,479
2023	29	434	$47,189
2024	34	533	$37,270

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	180	$86
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	45	73	$83
94726	Test to determine lung volumes using sensors	59	59	$25
94729	Test to examine how well the lungs exchange gases	58	58	$24
85018	Blood count, hemoglobin	30	30	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	204	8,310	$176,174
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	190	7,349	$155,209
Xolair	Omalizumab	13	364	$67,407
Fasenra Pen	Benralizumab	12	616	$66,590
Spiriva Respimat	Tiotropium Bromide	78	2,724	$45,513

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	14	$14,295
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	17	140	$10,437
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	44	$2,962
E1392	Portable oxygen concentrator, rental	Y	N/R	83	$2,784
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	12	$1,739

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amanda Murphy White, MD?

Tedicare shows public-source Medicare data for Amanda Murphy White, MD (NPI 1730404997), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Murphy White, MD have ACO affiliation data?

Amanda Murphy White, MD is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Amanda Murphy White, MD?

Amanda Murphy White, MD is linked to THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (billing NPI 1144657636) in the available physician profile data.

Does Amanda Murphy White, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.